Fast Track Designation was granted for BB-301 following U.S. Food and Drug Administration (FDA) review of positive interim clinical study results and proprietary Responder Analysis planned for use in ...
Frontera Energy Corporation (TSX: FEC) ("Frontera" or the "Company") today announced a plan to unlock significant value from its existing assets through a spin-off (the "Proposed Transaction" or the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback